Monitoring of bivalirudin anticoagulation during and after cardiopulmonary bypass using an ecarin-activated TEG system

J Card Surg. 2008 Jul-Aug;23(4):321-3. doi: 10.1111/j.1540-8191.2008.00604.x. Epub 2008 Jul 1.

Authors

Andreas Koster¹, Semih Buz, Thomas Krabatsch, Frank Dehmel, Roland Hetzer, Herman Kuppe, Cornelius Dyke

Affiliation

¹ Department of Anesthesia, Deutsches Herzzentrum, Berlin, Germany. koster@dhzb.de

PMID: 18482390
DOI: 10.1111/j.1540-8191.2008.00604.x

No abstract available

MeSH terms

Anticoagulants / pharmacokinetics*
Anticoagulants / therapeutic use
Blood Coagulation / drug effects*
Cardiopulmonary Bypass*
Drug Monitoring*
Endopeptidases / pharmacology*
Fibrinolytic Agents / pharmacology*
Hirudins / pharmacokinetics*
Humans
In Vitro Techniques
Peptide Fragments / pharmacokinetics*
Peptide Fragments / therapeutic use
Recombinant Proteins / pharmacokinetics
Recombinant Proteins / therapeutic use
Thrombelastography*
Whole Blood Coagulation Time

Substances

Anticoagulants
Fibrinolytic Agents
Hirudins
Peptide Fragments
Recombinant Proteins
Endopeptidases
ecarin
bivalirudin